1. PBAC (Pharmaceutical Benefits Advisory Committee). Guidelines for preparing submissions to the pharmaceutical benefits advisory committee. Australia: Australian Government Department of Health; 2013.
2. CADTH (Canadian Agency for Drugs and Technologies in Health). Guidelines for the economic evaluation of health technologies. Canada: CADTH; 2006.
3. HAS (Haute Autorité de Santé). Choices in methods for economic evaluation. France: HAS; 2012.
4. IQWiG (German National Institute for Quality and Efficiency in Health Care). General methods for the assessment of the relation of benefits to costs. Cologne: IQWiG; 2015.
5. CVZ (College voor zorgverzekeringen). Guidelines for pharmacoeconomic research: evaluation and actualisation. Diemen: CVZ; 2006.